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Background and Objective: Controversial results of the association between tea
(black tea, green tea, mate, and oolong tea) consumption and risk of bladder cancer
were reported among epidemiological studies. Thus, we performed a meta-analysis of
observational studies to investigate the association.
Methods: We searched the PubMed and Embase for studies of tea consumption
and bladder cancer that were published in any language up to March, 2016. Cohort
or case-control studies were included in the meta-analysis. All statistical analyses were
performed in Stata 12.0 software. Odds ratios (ORs) and 95% confidence intervals (CIs)
were calculated to assess the relationship between tea consumption and risk of bladder
cancer.
Results: Totally, 25 case-control studies (15 643 cases and 30 795 controls) and
seven prospective cohort studies (1807 cases and 443 076 participants) were included.
The meta-analysis showed that tea consumption was not significantly associated with
bladder cancer risk (OR = 0.96, 95% CI 0.86–1.06) (in a comparison of highest vs.
lowest category). No non-linearity association was observed between tea consumption
and bladder cancer risk (P = 0.51 for non-linearity). Specific analysis for black tea, green
tea, and mate yielded similar results. The dose-response analysis showed the summary
OR for an increment of 1 cup/day of tea consumption was 1.01 (95% CI 0.97–1.05).
Conclusion: Results based on current meta-analysis indicated that no significant
association was observed between tea consumption and risk of bladder cancer.
Keywords: bladder cancer, dose-response, risk factor, tea consumption, meta-analysis
INTRODUCTION
Bladder cancer is a very common disease worldwide, accounting for ∼429 800 new cases and 165
100 deaths occurred in 2012 worldwide (Torre et al., 2015). Although bladder cancer incidence
rates have been declining in most Western countries over the past decades, it remains an important
and deadly cancer in the United States (Siegel et al., 2015). Bladder cancer incidence rates have been
stable or declining over the past decades, and it may be owing to reductions in smoking prevalence,
increasing the intake of fruits and vegetables, and schistosomiasis control and treatment (Chavan
et al., 2014; Xu et al., 2015). However, feasible measures for the prevention of bladder cancer are
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still a miss. Therefore, more risk factors of bladder cancer should
be identified for the prevention of bladder cancer.
Tea is a commonly consumed beverage worldwide. Previous
research in vitro and in vivo has indicated that tea polyphenols
present protective effects against some cancers including bladder
cancer (Conde et al., 2014). Although the relationship between
tea consumption and risk of bladder cancer is biologically
plausible (Lu et al., 1999; Sagara et al., 2010), epidemiological
studies on this theme have obtained inconsistent results.
Two meta-analyses of observation studies concluded that tea
consumption was not associated with an elevated risk of bladder
cancer (Zeegers et al., 2001b; Qin et al., 2012). Nevertheless, a
recently published meta-analysis suggested that tea consumption
was associated with decreased risk of bladder cancer in Western
countries (Zhang et al., 2015). In addition, one meta-analysis
indicated that green tea reduced bladder cancer risk in Asians
(Wang X. et al., 2013), and the other one suggested that high
level of tea consumption in smokers was related to an elevated
risk of bladder cancer and high level of black tea intake in females
was related to a reduced risk of bladder cancer (Wu et al., 2013).
Therefore, the relationship between tea intake and the risk of
bladder cancer remains controversy. Additionally, none of above
published meta-analyses performed a dose-response analysis. In
order to clarify the relationship between tea consumption and the
risk of bladder cancer, we performed the present dose-response
meta-analysis of all published observational studies.
METHODS
Eligible Criteria
This study was conducted and reported following the preferred
reporting items for systematic reviews and meta-analyses
(PRISMA) statement (Moher et al., 2009). The inclusion criteria
were as following: (1) case-control study or cohort study; (2)
exposure was tea (including green tea, black tea, mate, and
oolong tea) consumption; (3) outcome was incidence of bladder
cancer; (4) study provided the odds ratios (ORs) or relative risks
(RRs) with corresponding 95% confidence intervals (CIs) or data
necessary to calculate them. When multiple papers reported on
the same study were identified, the most informative or complete
article would be included.
Search Strategy
PubMed and Embase were searched for studies examining the
relationship between tea consumption and bladder cancer that
were published in any language up to March, 2016. Search
items including “tea,” “drink,” “beverage,” or “fluid” combined
with “bladder cancer,” “bladder neoplasm,” “bladder tumor,”
“bladder carcinoma,” “urothelium carcinoma,” or “transitional
cell carcinoma” had been allied in the database retrieve. We also
scanned the reference lists from all retrieved papers to identify
additional studies. No restriction was applied.
Data Extraction
All data were extracted independently and crosschecked
by two reviewers according to the pre-specified inclusion
criteria. Discrepancy was resolved by discussion. The following
information were extracted: First author, publication year,
country, study period, sex, study design, type of control subjects
for case-control studies, sample size, type of tea, consumption
categories, the OR or RR with 95% CI for each category (the
results adjusted with most potential confounders), and adjusted
variables. Crude ORs or RRs with 95% CIs were only extracted
when no adjusted ORs or RRs were presented. In addition,
ORs or RRs with 95% CIs in different smoking status were
also extracted for assessing the effect of smoking, which is an
important confounding factor for bladder cancer.
Methodological Quality Assessment
Weperformedmethodological quality assessment of the included
studies using the Newcastle-Ottawa Scale (Stang, 2010; Zeng X.
et al., 2015), which is a nine-star scale contained threemain items:
Selection (0–4 stars), comparability (0–2 stars), and exposure (for
cohort study, 0–3 stars), or outcome (for case-control study, 0–3
stars).
Statistical Analysis
The statistical analysis for the overall relationship between tea
consumption and bladder cancer risk were based on random-
effects model and on comparisons of the highest vs. lowest
category of tea consumption (Zeng X. T. et al., 2015). The
measure of interest is the OR with corresponding 95% CI. For
studies reported the information by subsets (sex, smoking status,
type of tea), we summarized the ORs with 95% CIs of the subsets
in a fixed-effect model before aggregating them into overall
analysis.
For dose-response analysis, we used the G-L method
(Greenland, 1987; Orsini et al., 2012) to explore the relationship
between tea consumption and bladder cancer risk. The potential
non-linearity association was examined by modeling tea intake
using restricted cubic splines with three knots at 10, 50, and
95% of the distribution. We assigned the median or middle
point of the upper and lower boundaries in each category as
the corresponding dose to the related OR for each study. If the
highest category is open-ended, we assumed the both boundaries
to be the same as the closest category. The lowest boundary was
assumed to be zero if it was not present. Studies only reported
three levels or more were included in the dose-response analysis.
The Cochran Q and I2 statistics were applied to detect
statistical heterogeneity among studies (Higgins and Thompson,
2002). Heterogeneity was confirmed with a P-value of less than
0.1 or I2 value of more than 50%. To explore the potential
heterogeneity among studies, stratified analyses were performed
according to study design, sex, study location, smoking status,
adjustment for age, and adjustment for smoking. In addition,
subgroup analysis of type of tea had been carried out to
further investigate the association between different type of
tea consumption and the risk of bladder cancer. The meta-
regression analysis was conducted to detect the between-group
heterogeneity based on the aforementioned variables. Sensitivity
analysis was performed by removing the studies that only
provided crude ORs to examine the influence of these studies
on the summarized Ors (Leng et al., 2015). Publication bias was
detected by funnel plot and Egger’s regression method (Egger
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et al., 1997). All statistical analysis was performed with Stata
12.0 (StataCorp, College Station, TX). All statistical tests were
two-sided, with P < 0.05 considered statistically significant.
RESULTS
Study Characteristics
Detailed literature selection process was presented in Figure 1.
A total of seven prospective cohort studies (Heilbrun et al.,
1986; Chyou et al., 1993; Michaud et al., 1999; Nagano et al.,
2000; Zeegers et al., 2001a; Kurahashi et al., 2009; Ros et al.,
2011) included 443 076 participants, in which 1807 developed
bladder cancer, and 25 case-control studies (Morgan and Jain,
1974; Howe et al., 1980; Hartge et al., 1983; Ohno et al., 1985;
Jensen et al., 1986; Risch et al., 1988; Slattery et al., 1988; Clavel
and Cordier, 1991; Nomura et al., 1991; D’Avanzo et al., 1992;
Kunze et al., 1992; La Vecchia et al., 1992; Wilkens et al., 1996;
Bruemmer et al., 1997; Lu et al., 1999; Bianchi et al., 2000;
Geoffroy-Perez and Cordier, 2001; Woolcott et al., 2002; Wakai
et al., 2004; Bates et al., 2007; De Stefani et al., 2007; Demirel
et al., 2008; Jiang et al., 2008; Hemelt et al., 2010; Wang J. et al.,
2013) including 15 643 cases and 30 795 controls, published
from 1974 through 2013, were identified in the meta-analysis.
Characteristics of included studies were presented in Table 1. Of
FIGURE 1 | Flow diagram of literature search and study selection.
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TABLE 1 | Characteristics of studies of tea consumption and bladder cancer risk.
Study Sex Design Study
period
Country Cases/controls,
n
Type of tea and
consumption
categories
OR/RR (95% CI) Adjustments NOS
Morgan and Jain,
1974
Both HCC NR Canada 232/232 Tea, cups/day
(men)
None 4
0 1.00
0.1–0.9 0.38 (0.10–1.43)
1.0–2.9 0.72 (0.24–2.14)
3.0–4.9 1.24 (0.35–4.41)
≥5 0.45 (0.13–1.62)
Tea, cups/day
(women)
0 1.00
0.1–0.9 0.54 (0.25–1.17)
1.0–2.9 0.49 (0.26–0.94)
3.0–4.9 1.04 (0.51–2.13)
≥5 1.52 (0.65–3.53)
Howe et al., 1980 Both PCC 1974–1976 Canada 632/632 Tea (men) None 5
Never 1.0
Ever 1.0 (0.7–1.4)
Tea (women)
Never 1.0
Ever 0.5 (0.2–1.0)
Hartge et al., 1983 Both PCC 1977–1978 US 2982/5782 Tea, cups/wk
(men)
Age, race,
geographic
area, tobacco,
and coffee
6
0 1.0
0.1–7 1.1 (0.8–1.4)
7.1–14 1.1 (0.7–1.5)
>14 1.0 (0.7–1.4)
Tea, cups/wk
(women)
0 1.0
0.1–7 1.1 (0.7–1.7)
7.1–14 1.7 (1.0–2.9)
>14 1.2 (0.7–2.0)
Ohno et al., 1985 Both PCC 1976–1978 Japan 292/589 Black tea (men) Age and
smoking
7
Not 1.00
Ever 0.95 (0.68–1.32)
Black tea
(women)
Not 1.00
Ever 0.55 (0.29–1.03)
Jensen et al., 1986 Both PCC 1979–1981 Denmark 371/771 Tea, cups/day
(men)
Smoking 6
0 1.0
<2 0.8 (0.6–1.2)
2–4 2.1 (1.3–3.4)
4–6 1.5 (0.7–3.2)
Tea, cups/day
(women)
0 1.0
(Continued)
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TABLE 1 | Continued
Study Sex Design Study
period
Country Cases/controls,
n
Type of tea and
consumption
categories
OR/RR (95% CI) Adjustments NOS
<2 0.8 (0.4–1.5)
2–4 1.4 (0.6–3.0)
4–6 1.0 (0.4–2.5)
Heilbrun et al., 1986 M Cohort 1965–1985 US
(Japanese
ancestry)
57/7833 Black tea (men) Age and
smoking
8
Almost never 1.0
<twice/wk 1.4 (0.77–2.54)
2–4 times/wk 1.0 (0.38–2.60)
>once/day 0.8 (0.33–1.94)
Risch et al., 1988 Both PCC 1979–1982 Canada 876/1668 Tea (men) Life time
cigarette
consumption
and history of
diabetes
8
Not 1.00
Average daily
frequency
(3/day)
1.04 (0.90–1.20)
Tea (women)
Not 1.00
Average daily
frequency
(3/day)
0.98 (0.78–1.22)
Slattery et al., 1988 Both PCC 1977–1982 US 419/889 Tea, 8-ounce
servings/wk
(Never smoked)
Age, sex,
diabetes and
bladder
infections
8
0 tea 1.00
1–3 cups tea 1.91 (0.99–3.68)
≥4 cups tea 2.25 (1.29–3.91)
Tea, 8-ounce
servings/wk
(Ever smoked)
0 tea 1.00
1–3 cups tea 0.82 (0.54–1.25)
≥4 cups tea 0.84 (0.55–1.29)
Clavel and Cordier,
1991
Both HCC 1984–1987 France 690/690 Tea, cups/day
(men,
Non-smokers)
Age, hospital
and residence
6
0 1.00
1 2.73 (0.86–8.67)
>1 0.48 (0.05–4.60)
Tea, cups/day
(men, current
smokers)
0 1.00
1 3.81 (0.83–6.69)
>1 1.46 (0.28–7.62)
Tea, cups/day
(women,
Non-smokers)
0 1.00
1 0.85 (0.28–2.60)
>1 1.04 (0.31–3.59)
(Continued)
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TABLE 1 | Continued
Study Sex Design Study
period
Country Cases/controls,
n
Type of tea and
consumption
categories
OR/RR (95% CI) Adjustments NOS
Tea, cups/day
(women, current
smokers)
0 1.00
>0 0.19 (0.04–0.84)
Nomura et al., 1991 Both PCC 1977–1986 US
(Caucasian
and
Japanese)
261/522 Tea, cup-years
(men)
Smoking 8
Non-drinkers 1.0
Drinkers 0.8 (0.5–1.4)
1–30 0.9 (0.5–1.5)
≥31 0.7 (0.4–1.3)
Tea, cup-years
(women)
Non-drinkers 1.0
Drinkers 0.6 (0.2–1.5)
1–30 0.6 (0.2–1.6)
≥31 0.5 (0.2–1.8)
Black tea,
cup-years (men)
Non-drinkers 1.0
Drinkers 1.0 (0.7–1.5)
1–10 1.2 (0.8–1.8)
≥11 0.7 (0.4–1.2)
Black tea,
cup-years
(women)
Non-drinkers 1.0
Drinkers 0.6 (0.3–1.3)
1–10 0.6 (0.2–1.3)
≥11 0.7 (0.3–1.7)
D’Avanzo et al.,
1992
Both HCC 1985–1990 Italy 555/855 Tea Age, sex,
education,
smoking,
alcohol, and
exposure to
occupation
7
Non-drinkers 1.0
Drinkers 0.9 (0.6–1.2)
Kunze et al., 1992 Both HCC 1977–1985 Germany 620/675 Black tea,
cups/day (men)
Smoking 6
0 1.0
1–2 1.1 (0.8–1.4)
3–4 1.4 (0.8–2.2)
≥5 1.4 (0.7–3.1)
Black tea,
cups/day
(women)
0 1.0
1–2 0.7 (0.3–1.4)
3–4 0.7 (0.3–1.8)
≥5 0.7 (0.2–2.3)
(Continued)
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TABLE 1 | Continued
Study Sex Design Study
period
Country Cases/controls,
n
Type of tea and
consumption
categories
OR/RR (95% CI) Adjustments NOS
La Vecchia et al.,
1992
Both HCC 1983–1990 Italy 365/6147 Tea Age, sex, area
of residence,
education,
smoking, and
coffee
6
Non-users 1.0
Users (≥1
cup/day)
0.8 (0.5–1.1)
Chyou et al., 1993 Both Cohort 1965–1985 US
(Japanese
ancestry)
96/7995 Green tea Age and
smoking
8
Almost never 1.00
Ever 1.34 (0.79–2.27)
Black tea
Almost never 1.00
Ever 1.32 (0.87–2.00)
Wilkens et al., 1996 Both PCC 1979–1986 US
(Caucasian
and
Japanese)
271/522 Tea (men) Age, smoking,
occupation,
consumption
of dark green
vegetables in
men, and total
vitamin C
consumption
in women
8
Q1 (low) 1.0
Q2 0.8 (0.5–1.4)
Q3 1.0 (0.6–1.7)
Q4 (high) 0.7 (0.4–1.3)
Tea (women)
Q1 (low) 1.0
Q2 0.6 (0.2–1.4)
Q3 0.7 (0.3–1.8)
Q4 (high) 0.9 (0.4–2.2)
Green tea (men)
Q1 (low) 1.0
Q2 1.1 (0.6–1.9)
Q3 (high) 1.1 (0.6–2.3)
Green tea
(women)
Q1 (low) 1.0
Q2 0.8 (0.3–2.1)
Q3 (high) 0.9 (0.3–2.6)
Bruemmer et al.,
1997
Both PCC 1987–1990 US 262/405 Tea, cups per
day, wk, or mo
(men)
Age, country,
and smoking
8
≤1/mo 1.0
>1/mo–1/wk 0.6 (0.3–1.2)
>1/wk–7/wk 0.9 (0.5–1.6)
>7/wk 2.5 (1.2–5.3)
Tea, cups per
day, wk, or mo
(women)
≤1/mo 1.0
>1/mo–1/wk 0.3 (0.1–1.1)
>1/wk–7/wk 0.8 (0.3–1.8)
>7/wk 0.9 (0.4–2.1)
Lu et al., 1999 Both HCC 1996–1997 China
(Taiwan)
40/160 Tea Age, sex, date
of admission,
family history,
ethnicity, and
smoking
8
Non-drinkers 1.00
≤1/day 4.30 (0.51–35.88)
>1/day 2.77 (1.11–6.92)
Oolong tea
(Continued)
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TABLE 1 | Continued
Study Sex Design Study
period
Country Cases/controls,
n
Type of tea and
consumption
categories
OR/RR (95% CI) Adjustments NOS
Non-drinkers 1.00
Drinkers 3.00 (1.20–7.47)
Michaud et al., 1999 Both Cohort 1986–1996 US 252/47909 Tea (1 cup) Geographic
region, age,
smoking,
energy intake,
and intake of
fruits and
vegetables
6
<1/mo 1.0
1/mo–4/wk 0.98 (0.74–1.29)
5/wk–1/day 0.74 (0.49–1.11)
≥2/day 0.69 (0.40–1.19)
Bianchi et al., 2000 Both PCC 1986–1989 US 1452/2434 Tea, cups/day Age, sex,
education,
smoking,
family history,
occupation,
beverage,
chlorinated
surface water,
vegetable,and
coffee
7
None 1.0
<1 0.9 (0.7–1.1)
1–2.6 1.1 (0.9–1.3)
>2.6 0.9 (0.7–1.1)
Nagano et al., 2000 Both Cohort 1979–1981 Japan 114/38540 Green tea Age, gender,
radiation dose,
smoking,
education,
BMI, and
calendar time
6
0–1/day 1.00
2–4/day 1.07 (0.61–2.00)
≥5/day 1.07 (0.58–2.08)
Black tea
0/wk 1.00
1/wk 0.79 (0.45–1.33)
≥2/wk 0.81 (0.43–1.44)
Geoffroy-Perez and
Cordier, 2001
Both HCC 1984–1987 France 765/765 Tea, ml/wk (men) Age, center,
residence, and
smoking
6
0 1.00
1–950 1.42 (0.90–2.22)
>950 1.17 (0.72–1.90)
Tea, ml/wk
(women)
0 1.00
1–950 0.91 (0.39–2.13)
>950 1.08 (0.50–2.32)
Zeegers et al.,
2001a
Both Cohort 1986–1992 Netherland 569/3123 Tea, cups/day Age, sex,
smoking,
coffee
6
0 1.00
<2 0.64 (0.45–0.89)
2−>3 0.71 (0.53–0.93)
3−<4 0.51 (0.37–0.72)
4−<5 0.46 (0.34–0.64)
≥5 0.53 (0.39–0.74)
Woolcott et al., 2002 Both PCC 1992–1994 Canada 927/2118 Tea, cups/day Age, sex,
education,
smoking,
energy,
calcium, fiber,
and beer
7
<1 1.00
1–2 1.18 (0.97–1.43)
3–4 1.15 (0.89–1.49)
≥5 1.31 (0.92–1.87)
(Continued)
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TABLE 1 | Continued
Study Sex Design Study
period
Country Cases/controls,
n
Type of tea and
consumption
categories
OR/RR (95% CI) Adjustments NOS
Wakai et al., 2004 Both HCC 1994–2000 Japan 124/744 Green tea,
cups/day
Age, sex, year
of first visit,
and cigarettes
6
<1 1.00
1–4 1.40 (0.74–2.62)
5–9 2.67 (1.44–4.94)
≥10 1.18 (0.49–2.84)
Black tea,
cups/day
Almost never 1.00
Occasionally 0.96 (0.60–1.53)
≥1 0.16 (0.02–1.14)
Bates et al., 2007 Both PCC 1996–2000 Argentina 114/114 Mate con
bombilla, L/day
(ever-smoker)
Age, sex,
residence,
education,
cigarettes, and
an indicator
variable for
whether or not
the other type
of mate was
consumed at
that time
6
≤0.09 1.00
>0.09–0.36 1.36 (0.36–5.08)
>0.36–0.9 1.41 (0.57–3.46)
>0.9 1.16 (0.46–2.93)
Mate cocido,
L/day
(ever-smoker)
0 1.00
>0–<0.25 3.60 (0.31–41.3)
≥0.25 1.30 (0.65–2.60)
De Stefani et al.,
2007
Both HCC 1996–2000 Uruguay 255/501 Tea, cups/day Sex, age,
residence,
urban/rural
status,
education,
family history,
BMI,
occupation,
smoking,
coffee, soft,
and milk
6
Never drinkers 1.0
<1 2.1 (1.4–3.1)
≥1 4.1 (1.7–9.9)
Mate, L/day
Never drinkers 1.0
0.1–0.9 1.3 (0.6–2.7)
1.0–1.9 2.1 (1.2–3.9)
≥2.0 3.7 (1.9–7.1)
Demirel et al., 2008 Both HCC 2001–2006 Turkey 164/324 Black tea 0.74 (0.38–1.43) None 5
Jiang et al., 2008 Both PCC 1987–1999 US 1586/1586 Tea, cups/day Education,
carotenoids,
number of
years as a
hairdresser/barber,
and smoking
5
0 1.00
<1 0.96 (0.74–1.26)
1–2 0.95 (0.76–1.20)
3–4 1.16 (0.80–1.69)
≥5 0.88 (0.54–1.45)
Kurahashi et al.,
2009
Both Cohort 1990–2005 Japan 206/104440 Green tea,
cups/day (men)
Age, area,
smoking,
alcohol, and
coffee
8
<1 1.0
1–2 1.18 (0.73–1.91)
3–4 0.71 (0.43–1.18)
≥5 0.90 (0.56–1.45)
Green tea,
cups/day
(women)
(Continued)
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TABLE 1 | Continued
Study Sex Design Study
period
Country Cases/controls,
n
Type of tea and
consumption
categories
OR/RR (95% CI) Adjustments NOS
<3 1.0
3–4 1.22 (0.49–3.00)
≥5 2.29 (1.06–4.92)
Hemelt et al., 2010 Both HCC 2005–2008 China 381/371 Green tea,
cups/day
Age, sex,
smoking
7
No 1.00
<daily 0.83 (0.54–1.27)
Daily 1.02 (0.71–1.48)
<4 1.23 (0.76–1.97)
≥4 0.83 (0.53–1.28)
Black tea,
cups/day
No 1.00
<daily 0.82 (0.56–1.22)
Daily 0.86 (0.59–1.25)
<4 0.82 (0.49–1.37)
≥4 0.88 (0.57–1.38)
Ros et al., 2011 Both Cohort 1992–2000 European
countries
513/233236 Tea, ml/day Age, sex,
center,
smoking, and
energy intake
from fat and
Non-fat
sources
8
<12 for men;
<16 for women
1.00
12–199 for men;
16–263 for
women
1.09 (0.78–1.52)
≥200 for men;
≥264 for women
0.91 (0.64–1.30)
Wang J. et al., 2013 Both HCC 1999–2007 US 1007/1299 Tea, cups/day Age, sex,
ethnicity,
energy intake,
and smoking
7
Never 1.00
0.1–0.70 0.74 (0.59–0.92)
≥0.71 0.65 (0.53–0.81)
Black tea,
cups/day
Never 1.00
0.1–0.56 0.71 (0.57–0.88)
≥0.57 0.67 (0.54–0.83)
Green tea,
cups/day
Never 1.00
0.1–0.13 0.82 (0.61–1.11)
≥0.14 0.60 (0.45–0.79)
BMI, body mass index; HCC, hospital-based case-control; PCC, population-based case-control; NR, not report; OR, odds ratio; RR, relative risk; CI, confidence interval; NOS,
Newcastle-Ottawa Scale.
the 32 studies, seven were cohort studies, 12 were hospital-based
case-control studies, and 13 were population-based case-control
studies. Of these studies, 11 conducted in US (Hartge et al., 1983;
Heilbrun et al., 1986; Slattery et al., 1988; Nomura et al., 1991;
Chyou et al., 1993; Wilkens et al., 1996; Bruemmer et al., 1997;
Michaud et al., 1999; Bianchi et al., 2000; Jiang et al., 2008; Wang
J. et al., 2013), 9 in Europe (Jensen et al., 1986; Clavel and Cordier,
1991; D’Avanzo et al., 1992; Kunze et al., 1992; La Vecchia et al.,
1992; Geoffroy-Perez and Cordier, 2001; Zeegers et al., 2001a;
Demirel et al., 2008; Ros et al., 2011), 4 in Canada (Morgan and
Jain, 1974; Howe et al., 1980; Risch et al., 1988; Woolcott et al.,
2002), 4 in Japan (Ohno et al., 1985; Nagano et al., 2000; Wakai
et al., 2004; Kurahashi et al., 2009), two in China (Lu et al., 1999;
Hemelt et al., 2010), one in Argentina (Bates et al., 2007) and one
in Uruguay (De Stefani et al., 2007). The estimated quality of all
included studies was in the rage of 4–8 stars.
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Tea Consumption and Bladder Cancer
The meta-analysis of all 32 studies, no significant association
was observed between high tea consumption and risk of bladder
cancer (highest vs. lowest: OR = 0.96, 95% CI 0.86–1.06)
(Figure 2), with moderate to high heterogeneity (I2 = 54.2%,
Pheterogeneity). For cohort studies, the pooled OR was 0.88 (95%
CI 0.67–1.17), with certain between-study heterogeneity (I2 =
67.8%, Pheterogeneity = 0.005) (Table 2). For hospital-based case-
control studies, the pooled OR was 0.98 (95% CI 0.78–1.24),
with certain evidence of between-study heterogeneity (I2 =
63.2%, Pheterogeneity). For population-based case-control studies,
the pooled OR was 1.00 (95% CI 0.91–1.10), with no evidence of
between-study heterogeneity (I2 = 14.0%, Pheterogeneity).
Four cohort studies (Michaud et al., 1999; Nagano et al.,
2000; Zeegers et al., 2001a; Kurahashi et al., 2009) and 12
case-control studies (Morgan and Jain, 1974; Hartge et al., 1983;
Jensen et al., 1986; Clavel and Cordier, 1991; Kunze et al., 1992;
Lu et al., 1999; Bianchi et al., 2000; Woolcott et al., 2002; Wakai
et al., 2004; Jiang et al., 2008; Hemelt et al., 2010; Wang J.
et al., 2013) were included for the dose-response meta-analysis
of tea consumption. The results had been shown in Figure 3.
There was no evidence of a non-linearity association between
tea consumption and bladder cancer risk (Pnon-linearity = 0.51).
Thus, a linear regression model was applied. The summary
OR of bladder cancer for an increase of one cup of tea per
day was 1.01 (95% CI 0.97–1.05, Plinear = 0.73). For cohort
FIGURE 2 | The forest plot of tea consumption and the risk of bladder cancer.
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TABLE 2 | Meta-analysis of tea consumption and bladder cancer risk.
Type of tea and subgroups No. of studies Test of association I2 (%) P-for heterogeneity
OR (95% CI) P-value P-for within group P-for between group
Tea 32 0.96 (0.86–1.06) 0.39 54.2 <0.001 –
STUDY DESIGN
HCC 12 0.98 (0.78–1.24) 0.90 63.2 0.002 0.45
PCC 13 1.00 (0.91–1.10) 0.93 14.0 0.30
Cohort 7 0.88 (0.67–1.17) 0.38 67.8 0.005
SEX
Male 14 1.02 (0.92–1.13) 0.75 1.3 0.44 0.51
Female 13 0.93 (0.75–1.16) 0.51 22.8 0.21
STUDY LOCATION
America 17 0.99 (0.86–1.15) 0.94 61.9 <0.001 0.83
Europe 9 0.87 (0.70–1.07) 0.17 46.8 0.06
Asia 6 0.97 (0.78–1.21) 0.78 33.5 0.02
ADJUSTMENT FOR AGE
Yes 24 0.97 (0.84–1.10) 0.61 62.0 <0.001 0.75
No 8 0.99 (0.90–1.09) 0.86 0 0.57
ADJUSTMENT FOR SMOKING
Yes 27 0.96 (0.86–1.08) 0.49 59.5 <0.001 0.86
No 5 0.97 (0.79–1.19) 0.79 0 0.49
SMOKING STATUS
Non-smokers 2 1.54 (0.60–3.94) 0.37 60.9 0.11 0.26
Smokers 3 0.91 (0.61–1.36) 0.65 25.2 0.26
Black tea 10 0.84 (0.70–1.01) 0.06 34.9 0.13 –
STUDY DESIGN
HCC 5 0.79 (0.58–1.08) 0.14 42.8 0.14 0.28
PCC 2 0.80 (0.62–1.02) 0.07 0 0.51
Cohort 3 1.06 (0.75–1.50) 0.73 9.3 0.33
STUDY LOCATION
America 4 0.83 (0.58–1.18) 0.30 63.5 0.04 0.42
Europe 2 1.00 (0.56–1.80) 0.99 38.0 0.20
Asia 4 0.83 (0.66–1.04) 0.10 0 0.45
ADJUSTMENT FOR AGE
Yes 7 0.83 (0.66–1.05) 0.12 44.9 0.09 0.60
No 3 0.86 (0.58–1.27) 0.44 29.2 0.24
ADJUSTMENT FOR SMOKING
Yes 9 0.85 (0.69–1.04) 0.11 41.8 0.09 0.40
No 1 0.74 (0.38–1.44) 0.37 – –
Green tea 7 0.95 (0.73–1.24) 0.71 52.5 0.05 –
STUDY DESIGN
HCC 3 0.73 (0.53–1.00) 0.052 34.5 0.22 0.51
PCC 1 1.04 (0.59–1.84) 0.89 – –
Cohort 3 1.20 (0.90–1.59) 0.22 0 0.86
STUDY LOCATION
America 3 0.90 (0.53–1.54) 0.71 75.9 0.02 0.79
Asia 4 1.03 (0.53–1.54) 0.85 0 0.70
Mate 2 2.17 (0.70–6.74) 0.18 75.0 0.05 –
Oolong tea 1 3.00 (1.20–7.47) 0.02 – – –
HCC, hospital-based case-control; PCC, population-based case-control; OR, odds ratio; CI, confidence interval.
studies, no non-linearity association was observed (Pnon-linearity
= 0.11). The summary OR of bladder cancer for an increase of
1 cup/day of tea was 0.97 (95% CI 0.88–1.06, Plinear = 0.47).
For case-control studies, we found no evidence of a non-linearity
association between tea consumption and bladder cancer risk
(Pnon-linearity = 0.60). We then used the linear model among
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case-control studies. The pooled OR of bladder cancer for an
increase of 1 cup/day was 1.02 (95% CI 0.98–1.06, Plinear =
0.27).
FIGURE 3 | The dose-response analysis of tea consumption and the
risk of bladder cancer. The black solid line and the black long dashed line
represent the estimated RRs and corresponding 95% CIs for the non-linearity.
The red solid line and the red short dashed line represent the estimated RRs
and corresponding 95% CIs for the linearity.
Black Tea Consumption and Bladder
Cancer
Black tea consumption was examined in 3 cohort
studies (Heilbrun et al., 1986; Chyou et al., 1993; Nagano
et al., 2000), 5 hospital-based case-control studies (Kunze et al.,
1992; Wakai et al., 2004; Demirel et al., 2008; Hemelt et al.,
2010; Wang J. et al., 2013), and 2 population-based case-control
studies (Ohno et al., 1985; Nomura et al., 1991). No significant
association was observed between black tea consumption and
risk of bladder cancer (OR= 0.84, 95% CI 0.70–1.01) (Figure 4),
with moderate between-study heterogeneity (I2 = 34.9%,
Pheterogeneity = 0.13). For cohort studies, the combined OR was
1.06 (95% CI 0.75–1.50), with low between-study heterogeneity
(I2 = 9.3%, Pheterogeneity = 0.33) (Table 2). For hospital-based
case-control studies, the pooled OR was 0.79 (95% CI 0.58–
1.08), with low to moderate between-study heterogeneity (I2 =
42.8%, Pheterogeneity = 0.14). For population-based case-control
studies, the combined OR was 0.80 (95% CI 0.62–1.02), with
no between-study heterogeneity (I2 = 0.0%, Pheterogeneity =
0.51).
Four case-control studies (Kunze et al., 1992; Wakai
et al., 2004; Hemelt et al., 2010; Wang J. et al., 2013) were
included for the dose-response meta-analysis of black tea
consumption. The results had been shown in Figure 5.
FIGURE 4 | The forest plot of black tea consumption and the risk of bladder cancer.
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There was no evidence of a non-linearity association
between black tea consumption and bladder cancer risk
(Pnon-linearity = 0.06). A linear model was used among these
studies. The poled OR of bladder cancer for an increase
of 1 cup/day of black tea was 0.89 (95% CI 0.76–1.05,
Plinear = 0.18).
FIGURE 5 | The dose-response analysis of black tea consumption and
the risk of bladder cancer. The black solid line and the black long dashed
line represent the estimated RRs and corresponding 95% CIs for the
non-linearity. The red solid line and the red short dashed line represent the
estimated RRs and corresponding 95% CIs for the linearity.
Green Tea Consumption and Bladder
Cancer
Green tea consumption was assessed in 3 cohort studies (Chyou
et al., 1993; Nagano et al., 2000; Kurahashi et al., 2009), 3 hospital-
based case-control studies (Wakai et al., 2004; Hemelt et al., 2010;
Wang J. et al., 2013), and one population-based case-control
FIGURE 7 | The dose-response analysis of green tea consumption and
the risk of bladder cancer. The black solid line and the black long dashed
line represent the estimated RRs and corresponding 95% CIs for the
non-linearity. The red solid line and the red short dashed line represent the
estimated RRs and corresponding 95% CIs for the linearity.
FIGURE 6 | The forest plot of green tea consumption and the risk of bladder cancer.
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study (Wilkens et al., 1996). No significant association was
observed between green tea consumption and bladder cancer
risk (OR = 0.95, 95% CI 0.73–1.24) (Figure 6), with moderate
heterogeneity (I2 = 52.5%, Pheterogeneity = 0.05). For cohort
studies, the combined OR was 1.20 (95% CI 0.90–1.59), with
no heterogeneity (I2 = 0.0%, Pheterogeneity = 0.86) (Table 2). For
hospital-based case-control studies, the pooled ORwas 0.73 (95%
CI 0.53–1.00), with moderate between-study heterogeneity (I2 =
34.5%, Pheterogeneity = 0.22). For population-based case-control
studies, the combined OR was 1.04 (95% CI 0.59–1.84).
Two cohort studies (Nagano et al., 2000; Kurahashi et al.,
2009) and three case-control studies (Wakai et al., 2004; Hemelt
et al., 2010; Wang J. et al., 2013) were included for the dose-
responsemeta-analysis of green tea consumption. The results had
been shown in Figure 7. No evidence of non-linearity association
was detected between green tea consumption and bladder cancer
risk (Pnon-linearity = 0.92). A linear model suggested that the
summary OR of bladder cancer for an increase of 1 cup/day of
green tea was 1.02 (95% CI 0.94–1.1, Plinear = 0.66).
Mate and Oolong Tea Consumption and
Risk of Bladder Cancer
Mate consumption was investigated in 2 case-control studies
(Bates et al., 2007; De Stefani et al., 2007). No significant
association was observed between mate consumption and
bladder cancer risk (OR = 2.17, 95% CI 0.70–6.74), with
moderate to high between-study heterogeneity (I2 = 75.0%,
Pheterogeneity = 0.05) (Table 2).
FIGURE 8 | Sensitivity analysis of tea consumption and risk of bladder cancer.
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Oolong tea consumption was examined in only one study
(Lu et al., 1999). An elevated risk was observed between oolong
tea consumption and bladder cancer risk (OR = 3.00, 95% CI
1.20–7.47) (Table 2).
Subgroup and Meta-Regression Analyses
Results of subgroup analyses had been shown in Table 2. For
tea consumption and risk of bladder cancer, subgroup analyses
defined by study design, sex, study location, adjustment for
age, adjustment for smoking, and smoking status did not show
any substantial change in the summary OR, with no evidence
of between-group heterogeneity by meta-regression analysis
(Table 2). For black tea consumption and risk of bladder cancer,
subgroup analyses defined by study design, study location,
adjustment for age, and adjustment for smoking did not show
any substantial change in the summary OR, with no evidence
of between-group heterogeneity by meta-regression analysis
(Table 2). For green tea consumption and risk of bladder cancer,
subgroup analyses defined by study design and study location
did not show any substantial change in the summary OR, with
no evidence of between-group heterogeneity by meta-regression
analysis (Table 2). Sensitivity analysis by removing four studies
(Morgan and Jain, 1974; Howe et al., 1980; Zeegers et al., 2001a;
Demirel et al., 2008) with crude ORs did not change the overall
results of tea consumption among all studies(OR = 0.99, 95%
CI 0.89–1.10), cohort studies (OR = 1.02, 95% CI 0.84–1.23),
hospital-based case-control studies (OR = 1.01, 95% CI 0.78–
1.32), and population-based case-control studies (OR = 1.00,
95% CI 0.90–1.11),; but the heterogeneity was reduced in cohort
studies (I2 = 14.8%, P = 0.32 for heterogeneity) (Figure 8).
Publication Bias
No evidence of publication bias was detected in the tea (P = 0.43
for Egger’s test; Figure 9), black tea (P = 0.76 for Egger’s test;
Figure 10), and green tea (P = 0.06 for Egger’s test; Figure 11)
consumption.
DISCUSSION
In present meta-analysis of seven prospective cohort studies
that including 443 076 participants and 25 case-control studies
that included 15 643 cases and 30 795 controls, we found that
high level of tea intake was not significantly associated with
bladder cancer risk. Specific analyses for black tea, green tea,
and mate yielded similar results except for oolong tea. Dose-
response analyses showed that there was no non-linearity or
linearity association between tea intake and bladder cancer risk.
There are two concerns to the previously published meta-
analysis. For instance, dose-response relationship were left
unaddressed and only reported data for the highest vs. lowest
comparison in two studies (Zeegers et al., 2001b; Qin et al.,
2012), and type of tea was not considered in one study (Zeegers
et al., 2001b). Accordingly, we performed this study with refined
methods, and we obtained results consistent with the previous
ones. Tea is a mixture of a large number of bioactive compounds.
Certain laboratory studies in multiple animal models have
suggested that green tea extract or polyphenols could inhibit
FIGURE 9 | Funnel plot for tea consumption and risk of bladder cancer.
FIGURE 10 | Funnel plot for black tea consumption and risk of bladder
cancer.
FIGURE 11 | Funnel plot for green tea consumption and risk of bladder
cancer.
the activity of tumor at different organ site (Yang et al., 2009;
Yang and Wang, 2011). Therefore, it is not clear from these
observational studies whether the tea extractor or polyphenols
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are beneficial and randomized controlled trials or controlled
feeding studies would help examine this problem.
Several limitations should be taken into consideration for
our study. First, limitations of observational studies contain
the problem of residual confounding that may also extend
to meta-analysis of observational studies (Threapleton et al.,
2013). The quality and usefulness of any meta-analytic study
are dependent on the quality and comparability of information
from the individual studies (Hennekens and Demets, 2009;
Zhou et al., 2011). Second, our meta-analysis included studies
performed in different countries since the 1970s, and some
studies had certain weakness in study design that were without
stratification of type of tea, and some studies did not adjust
confounders. Most of the studies included in this meta-analysis
adjusted for important confounding factors such as age, sex,
and smoking in their analyses, but not all studies adjusted
for other potentially important variables such as occupation or
other dietary factors (e.g., alcohol, coffee, vegetables, and fruits).
However, the meta-regression and subgroup analyses based
on those factors did not observe any difference. Additionally,
bladder cancer is a complicated and heterogeneous disease,
which is noted for marked global variations in incidence and
etiology. Therefore, the results of the present meta-analysis
should be considered with certain caution because of potential
confounding. Third, measurement error in dietary assessment
is an inherent problem when evaluating relationships between
diet and diseases (Threapleton et al., 2013). The potential
for exposure misclassification of tea consumption was also a
limitation. The interval between lowest and highest categories
was different among included studies. Moreover, the unit of
tea consumption was also much different among identified
studies. The aforementioned two factors may contribute to
the heterogeneity among studies in the aggregated analysis.
Indeed, we detected moderate to high heterogeneity among
included studies. Fourth, as we all know, green tea is popular in
East Asians such as Chinese and Japanese population, and the
sample size of Asians in this meta-analysis was relatively small.
Therefore, the selection bias was inevitable and the relationship
among different countries still remained unclear. Lastly, we did
not search for unpublished studies; therefore, even though no
publication bias was detected through funnel plot and Egger’s
regression method, the publication bias might be inevitable.
Lastly, the results of this meta-analysis showed that oolong
tea consumption was associated with increased risk of bladder
cancer. However, this finding was found only derived from one
study (Lu et al., 1999). This intriguing finding wants further
studies to investigate.
A major strength of this meta-analysis was the inclusion of
observational studies from two main online database searches,
identifying published studies from over two decades. The quality
of the present meta-analysis was strengthened by assessing
the quality of included studies and exploring dose-response
relation not only reporting the comparisons of highest and
lowest tea consumption. Different type of tea may have different
influence. Therefore, we have evaluated the relationship between
different type of tea and bladder cancer risk, which was an
additional strength. Despite certain between-study heterogeneity
was examined, the findings were generally consistent and the
most of estimations were less than one. Therefore, drinking tea
appears to be safe at habitual use.
In conclusion, this meta-analysis, consisting of 25 case-control
studies and 7 cohort studies, had indicated that there was no
significant association between tea consumption and the risk of
bladder cancer. However, certain caution is need in interpreting
the results from the present meta-analysis because of potential
confounders and misclassification of tea consumption. Further
studies with high quality and well-designed large scale are needed
to provide more precise evidence.
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